MDY Healthcare Share Discussion Threads

[simonparker5] 26/10/2011 07:05

Well done Jimmy, I assume you are invested here? Looks like you are going to be very well rewarded today!

[jimmyloser] 26/10/2011 07:04

TIDMMDY

RNS Number : 8576Q

MDY Healthcare PLC

26 October 2011

MDY Healthcare plc

Realisation of investment

26 October 2011: The Board of MDY Healthcare plc ("MDY Healthcare" or, the "Company"), the strategic investor in healthcare companies, is pleased to announce that the Company will realise its investment in Medivance, Inc. ("Medivance"), subject to the completion of the acquisition of Medivance by C.R. Bard Inc., (a NYSE listed company) for a total cash consideration of approximately US$250 million (the "Transaction"). Completion of the Transaction is expected to occur in Q4 2011, conditional on receipt of US anti-trust clearances.

On completion of the Transaction, the directors of MDY Healthcare anticipate that the Company will receive an estimated gross cash consideration of between US$20 million (GBP12.500 million) and US$21million (GBP13.125 million) for the sale of its 10.4 per cent. holding in Medivance, depending on certain completion adjustments. MDY Healthcare will make a further announcement on completion of the Transaction, confirming the gross cash consideration received.

MDY Healthcare has invested approximately $6 million in Medivance in total through a series of investments. The Company's last investment was in June 2009 when it invested $1 million.

MDY Healthcare currently has total outstanding indebtedness of approximately GBP1.65 million plus accrued interest. On receipt of proceeds, the Company will repay all outstanding debt together with all accrued interest.

Following the realisation of the Company's investment in Medivance, Stanmore becomes the Company's sole investment. The Company will make a further announcement in due course about the Company's strategy going forward and the use of the balance of the proceeds from the realisation of Medivance.

Further information on Medivance can be obtained on Medivance's website, www.medivance.com.

Grahame Cook, Chairman of MDY Healthcare said:"We are delighted to announce the realisation, in cash, of our investment in Medivance. The proceeds represent a substantial premium to our investment of approximately $6 million and are considerably in excess of our current market capitalisation of approximately GBP2.2 million. We will be making an announcement in the near future setting out our strategy for the Company and the use of the balance of the proceeds."

[jimmyloser] 25/10/2011 23:06

C.R. Bard to acquire Medivance for $250 million
by Associated Press | Oct 25, 2011 5:25 PM ET

inShare0 0MURRAY HILL, N.J. - Medical technology company C. R. Bard Inc. said Tuesday that it has reached an agreement to acquire Medivance Inc. for $250 million.

Once the transaction is completed, Medivance will become part of Bard Medical division.

Medivance, based in Louisville, Colo., offers medical technology in the field of therapeutic hypothermia. Accurate manipulation of body temperature is used for a variety of critically ill patients.

Medivance is a good fit in C.R. Bard's critical care business and their technology addresses a large unmet need in a market that's growing double digits, Bard CEO Timothy M. Ring said in a statement.

Based on the anticipated completion of the merger in the fourth quarter, Bard expects the dilution impact to be immaterial to earnings per share in 2011.

Bard, headquartered in Murray Hill, N.J., provides medical technologies in the fields of vascular, urology, oncology and surgical specialty products.


Read more:

[dinky rinky] 11/10/2011 10:03

The Wanted have even brought a single out about it !!

[monte1] 10/10/2011 20:26

10p bid?

Overvalued by around 9.99 p imo.

[zyxwvutsrqponmlkjihgfedcba] 10/10/2011 20:25

It was dated 20th july,, but our James is not known for being on the ball.

[dinky rinky] 10/10/2011 19:40

The Stanmore news has an immediate impact but in the wrong direction !!

10p bid........... an all time low.

Another consolidation on the way ?

[jimmyloser] 09/10/2011 13:24

Stanmore receives £4m investment from Imperial Innovations Group plcProceeds to finance expansion of distribution in UK and US and new product development

20 July 2011 - Stanmore Implants ("Stanmore"), specialists in the design and manufacture of patient specific implants for complex orthopaedic reconstructions, announces today that it has received £4m in equity investment from Imperial Innovations Group plc.

This news follows the announcement in June that Stanmore had received US FDA 510k approval for its Juvenile Tumour System ("JTS") non-invasive extendible distal femoral replacement ("JTS implant"), for use in paediatric orthopaedic oncology surgery. Stanmore is now launching the JTS in the United States market and the proceeds will be used in part to help build a specialist sales force for this important product. The proceeds will also be used to support the development of Stanmore's other innovative and differentiated new technologies. These include the Savile Row System, the world's first fully personalised early knee replacement surgery system that combines patient specific implants with a proprietary robotic intra-operative system, and ITAP, a novel approach to enabling the direct attachment of an exoprosthesis to the skeleton of amputees, thereby giving the patient greater mobility and comfort over traditional socket based systems.

Prior to today's fundraising, Stanmore has previously raised finance from Abingworth, specialist investors in life sciences, as well as Ivy Capital and MDY Healthcare plc.

In addition to the financing, Stanmore welcomes John Holden to the Board of Stanmore as a non-executive director. He is Director of Investments at Imperial Innovations having joined in 2007. He spent the first six years of his career as a corporate financier in the City and then eight years with 3i.

Brian Steer, Executive Chairman of Stanmore, said:

"We are delighted to welcome Imperial Innovations to our shareholder base. Whilst we have a solid core business generating increased revenues, we now have the funds to accelerate the development of our new, groundbreaking technologies and drive the commercialisation of our non-invasive extendible implants in the UK and the US."

Susan Searle, Imperial Innovations' CEO, said:

"We are excited to work with Stanmore and believe their unique product and service offering is well placed to grow in the future. We look forward to working with Brian and his team as Stanmore enters the next phase in its growth."

End

[hotfinance14] 30/9/2011 09:46

Apply Jimmy.

[jimmyloser] 30/9/2011 08:37

UK Sales & Marketing Manager job in London at Medivance ...
Job Description: The Company is seeking applications for the position of:- UK Sales & Marketing Manager Job Description To assume full responsibility for ...
jobhits.co.uk/view-job/UK-Sales-Marketing.../fo7fb.html

[jimmyloser] 21/9/2011 19:19

Scuttling soon. lol.

What a lovely word 'scuttling' is.

[dinky rinky] 21/9/2011 15:31

The ship is almost deserted.

Scuttling soon !!

[hotfinance14] 17/9/2011 19:35

I will still hold then Jimmy.

[jimmyloser] 17/9/2011 10:09

3735 - Appalling, but true. It is all that they are good for.

Hot

PG= Peter Gyllenhammer, he is Swedish and an abitrageur.

Arbitrageur - Definition of Arbitrageur on Investopedia - A type of investor who attempts to profit from price inefficiencies in the market.

It seems that he felt that MDY was being badly managed and so invested heavily and became an activist shareholder who wanted the sum of the parts to be broken up to realise shareholder value and subsequently make a decent return on his investment.

The original management have departed and new guys are doing the clean up act, they are making an excellent job of it (imo).

This week they jettisoned the ill fated Trust William.

They are left with low running costs and the two very valuable and saleable assets. (imo)

Stanmore and Medivance - I expect Stanmore could be next and then we will be left with Medivance. For those still holding MDY shares, it is felt that Medivance are the jewel in the crown. I am hoping for between 30p and 50p a share next year especially if Medivance are either bought or IPO..

all, imo/dyor

[forcemode] 17/9/2011 02:53

Need some "TIPS"?

Sorry, couldn't resist, exits stage left!

[hotfinance14] 16/9/2011 14:04

Who is PG ?

[dinky rinky] 16/9/2011 11:38

The best recommendation I've ever seen for investing in MDY, courtesy JL:-

"Invest in MDY to guarantee losses that can be offset against other capital gains"

That'll teach that nasty tax man, that'll keep him at bay !!!

[jimmyloser] 15/9/2011 16:18

Hot,

Hard to believe, but I would sit tight. I am riding this one out to the end, if PG is steering then that in itself is good enough for me

Stanford and Medivance are without any doubt, the jewels in a very tarnished crown.

Medivance is possibly worth 35/45p per share I reckon. impo

They will (Medivance) either sell or IPO and possibly next year, hence all of the marketing, its not the product that they are pushing, its the company!! (imo)

A great clean up job has been executed here and for me will result in some losses to offset against expected cap gains!!

imo/dyor

[south_london] 15/9/2011 16:14

Hot
you you find him on GON

[hotfinance14] 15/9/2011 16:11

Jimmy...your still alive then...whats the position with the stock these days ? I still hold but got very bored with it.

[south_london] 15/9/2011 15:45

Yes Jim it looks like you are talking to your self where has everyone gone over to GON maybe ? or down the pub

[jimmyloser] 15/9/2011 10:09

I know that I am talking to myself.

Jimmy, more good news from Graham and the team

Did you know just how successful Medivance have become?
Very


LOUISVILLE, Colo., Sept. 13, 2011 /PRNewswire/ -- Building on a track record of serving the nation's top ranked hospitals, Medivance® Inc. is pleased to announce that on the U.S. News & World Report 2011-12 Honor Roll, all of the first 10 hospitals are users of its Targeted Temperature Management(TM) product, the Arctic Sun®. The announcement was made by Robert Kline, President & CEO, who stated, "It is often said that you are known by the company you keep, and we are honored to be affiliated with the top tier of the U.S. News 2011-2012 Honor Roll. The Medivance Team is very proud of this achievement."

Body temperature, systematically measured and reported as a vital sign, contributes to maintenance of normal physiology and affects the processes leading to recovery after illness. Intentional manipulation of body temperature has therefore emerged as a key treatment strategy for hospitals. The Medivance® Arctic Sun® brings precision Targeted Temperature Management(TM) to the highest level of performance available today for intentionally manipulating body temperature as a treatment strategy.

"Our Arctic Sun® 5000 is really the only product in the market that can achieve, with precision, a prescribed order set for temperature management with consistency for each patient. This is of particular importance in the hospital environment for Continuous Quality Improvement , thus it's not surprising the highest-performing Honor Roll hospitals make use of our technology," Kline explained.

The hospitals are Johns Hopkins Hospital, Baltimore; Massachusetts General Hospital, Boston; Mayo Clinic, Rochester, Minn.; Cleveland Clinic; Ronald Reagan UCLA Medical Center, Los Angeles; New York-Presbyterian University Hospital of Columbia and Cornell, N.Y.; UCSF Medical Center, San Francisco; Brigham and Women's Hospital, Boston; Duke University Medical Center, Durham, N.C.; and Hospital of the University of Pennsylvania, Philadelphia.

The Honor Roll, which lists 17 hospitals overall, was released July 19 online and will be available on newsstands through November 29. Quoting the U.S. News website: "A place on the Best Hospitals Honor Roll is reserved for medical centers that demonstrate unusually high expertise across multiple specialties, scoring at or near the top in at least six of 16 specialties. Just 17 of the nearly 5,000 hospitals evaluated for the 2011-12 rankings qualified. Hospitals with the highest scores in a given specialty received 2 Honor Roll points; those with slightly lower scores received 1 point.* Honor Roll standing was determined by the total number of Honor Roll points across all 16 specialties." For more information, visit: .

In June, Mr. Kline received the Ernst & Young Entrepreneur Of The Year® 2011 Mountain Desert Award in the Health Care & Life Sciences category. According to Ernst & Young LLP, the award recognizes outstanding entrepreneurs who demonstrate excellence and extraordinary success in such areas as innovation, financial performance and personal commitment to their businesses and communities. Mr. Kline was selected by an independent panel of judges, and the award was presented at a gala event at the Denver Center for the Performing Arts on June 16, 2011. For more information, visit:

About Medivance® Inc.

Medivance®, founded in 1998, has grown from a pure start-up to market leadership in the rapidly expanding field of Targeted Temperature Management(TM) therapy. The company's flagship Arctic Sun® Temperature Management System has been utilized to treat tens of thousands of critically ill patients throughout the world. Medivance employs over 50 employees in the Boulder Valley and nearly 100 worldwide. For more information, visit:



Read more: Medivance® Inc. Arctic Sun Products Are the Preferred Choice of 2011 U.S. News & World Report Top-10 Ranked Honor Roll Hospitals - The Denver Post
Read The Denver Post's Terms of Use of its content:

[dinky rinky] 03/8/2011 16:39

The only share on my monitor that's not red today !!

What a star.

LOL

[space cadet 32b] 26/7/2011 18:23

does avoint mean clueless, drunken spaz in Arabic?